In addition, p53C peptide fused with CPP inhibits the proliferation of cancer cells by reactivating endogenous p53, and significantly increases lifespan in animal models of terminal peritoneal carcinomatosis and bladder cancer in vivo [29-31]. This evidence concerns the gene TP53 and urinary bladder cancer.